First Author | Seeling M | Year | 2013 |
Journal | Proc Natl Acad Sci U S A | Volume | 110 |
Issue | 26 | Pages | 10729-34 |
PubMed ID | 23754379 | Mgi Jnum | J:197378 |
Mgi Id | MGI:5492245 | Doi | 10.1073/pnas.1301001110 |
Citation | Seeling M, et al. (2013) Inflammatory monocytes and Fcgamma receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice. Proc Natl Acad Sci U S A 110(26):10729-10734 |
abstractText | Destruction of bone tissue by osteoclasts represents a severe pathological phenotype during inflammatory arthritis and results in joint pain and bone malformations. Previous studies have established the essential role of cytokines including TNFalpha and receptor-ligand interactions, such as the receptor activator of nuclear factor-kappa B-receptor activator of nuclear factor-kappa B ligand interaction for osteoclast formation during joint inflammation. Moreover, autoantibodies contribute to joint inflammation in inflammatory arthritis by triggering cellular fragment crystallizable (Fc)gamma receptors (FcgammaR), resulting in the release of proinflammatory cytokines and chemokines essential for recruitment and activation of innate immune effector cells. In contrast, little is known about the expression pattern and function of different FcgammaRs during osteoclast differentiation. This would allow osteoclasts to directly interact with autoantibody immune complexes, rather than being influenced indirectly via proinflammatory cytokines released upon immune complex binding to other FcgammaR-expressing innate immune cells. To address this question, we studied FcgammaR expression and function on osteoclasts during the steady state and during acute joint inflammation in a model of inflammatory arthritis. Our results suggest that osteoclastogenesis is directly influenced by IgG autoantibody binding to select activating FcgammaRs on immature osteoclasts, resulting in enhanced osteoclast generation and, ultimately, bone destruction. |